Company Data
Summit Therapeutics Inc.
Ticker
SMMT
Current Price
$21.37 -2.06%
Market Cap
$15.8B
Price Target
Refer to Report
Volume
2.3M
52wk Range
$2.1 - $33.89
Overview
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.